Saturday, May 25, 2019

Juniper Research: Digital Therapeutics Market to Exceed $32 billion by 2024 Offering Mixed Fortunes for Drug Companies

BWW News Desk
May 15, 2019

A new report from Juniper Research has found that the market for digital therapeutics (software that augments or replaces traditional therapies), will expand rapidly over the next 5 years; reaching over $32 billion in revenues in 2024, up from an estimated $2.2 billion in 2019.

The report, Digital Therapeutics & Wellness: Disruption, Innovation Opportunities & Forecasts 2019-2024, found that the biggest application for digital therapeutics will be diabetes and weight loss; generating over $19 billion in 2024. This sector, led by companies like Omada, Virta Health and Welldoc, has taken an early lead, as lifestyle changes have a more demonstrable impact on diabetes than other conditions.

However, Juniper expects higher growth to occur in ‘other conditions’, such as chronic obstructive pulmonary disorder treatment, VR for PTSD, and computer games to help with developmental disorders.

For more insights on digital therapeutics’ impact for the future of medicine, download our free white paper, Are Digital Therapeutics a Poison or Tonic for Drug Companies?

Universal Interest, but not Universal Payment

While healthcare insurers are leading the way in distributing digital therapeutics, the report notes a strong interest amongst employers. With reimbursement still largely unresolved, Juniper expects that the majority of revenue will arise from direct payments from employers until 2021, and public health interest to be confined to a handful of markets.

Wellness Apps on the Up

Wellness apps, which frequently claim less quantified health benefits but are otherwise similar to digital therapeutics, are also on the rise. Juniper expects over 870 million consumer wellness apps to be in use by 2024; generating over $5 billion in revenue. In contrast, employer wellness apps will be worth $20 billion in the same period.

“While our research shows that employee schemes typically have a lower revenue per user than consumer payers, they will pay for longer,” remarked research author James Moar. “They also do not compete directly with free wellness apps, a constant problem for the B2C wellness industry, which has also constrained B2C digital therapeutics.”

Juniper Research provides research and analytical services to the global hi-tech communications sector; providing consultancy, analyst reports and industry commentary.

SOURCE: BUSINESS WIRE. ©2015 Business Wire

Comments

Registration Login
Registration Login
Registration Login
Registration